Pharmafile Logo
Pharmafocus logo
Advanced Search

Germany

Showing 15 posts of 45 posts found.

Watchdog resignation forced ‘to appease pharma’

September 6, 2010
Sales and Marketing Germany, IQWIG

The head of Germany’s medicines cost-effectiveness watchdog was forced to resign because he was a vocal critic of the pharma …

News

Germany raises health premiums to tackle budget deficit

July 9, 2010
Sales and Marketing Germany, economic climate, insurance

Chancellor Angela Merkel’s coalition government has agreed to raise health insurance premiums by over half a percent in a further …

News
Rosler and Merkel

Germany and UK to seize control of medicines prices

July 1, 2010
Sales and Marketing Germany, Lansley, PPRS, UK, global pricing, price cuts

 Major changes are afoot in Germany and the UK, the last two European countries with ‘free pricing’ of pharmaceuticals. Governments …

News

German patent setback for GlaxoSmithKline’s Seretide

May 21, 2010
Sales and Marketing GSK, Germany, Seretide

A Munich court has ruled GlaxoSmithKline’s combination patent for its asthma and COPD treatment Seretide is not valid. The Federal …

News

German price cuts denounced by industry

March 30, 2010
Sales and Marketing Germany, IQWIG

Pharma industry organisations have reacted angrily to new government plans in Germany which would enforce mandatory price reductions one year …

News

German Health Minister attacks ‘pharma monopoly’

March 10, 2010
Sales and Marketing Germany, cost-effectiveness, price cuts, prices

German Health Minister Philipp Rösler wants to break pharma’s ‘monopolistic hold’ over the country by introducing price limits on new …

News

EU should require all trials to be registered, says IQWiG

December 1, 2009
Sales and Marketing Germany, IQWIG, health economics, hta

 Germany’s Institute for Quality and Efficiency in Health Care (IQWiG) has said that registration and publication of all clinical trials …

News

Eurozone’s biggest economies make surprise rebound, in time for German elections

September 7, 2009
Research and Development, Sales and Marketing France, Germany, healthcare

News

UCB and Novartis expand alliance in Germany

September 1, 2009
Sales and Marketing Germany, Novartis, UCB

UCB and Novartis have extended their partnership in Germany with a new licensing deal for the cardiovascular and diabetes drug …

News

GSK freezes prices in Germany as part of PR trail

April 24, 2009
Sales and Marketing GSK, Germany

GlaxoSmithKline has announced a price freeze on its drugs and vaccines in Germany for 2009. The freeze applies to drugs …

News

The Pharmafocus Interview: Elmar Schnee

January 6, 2009
Sales and Marketing EU, Germany, IQWIG, Merck Serono, cost-effectiveness

Germany's Merck has the kind of business model that investors warm to during times of recession. The company is the …

Feature

Bayer calls for R&D tax breaks in Germany

December 17, 2008
Sales and Marketing Germany

Bayer has called for more tax breaks to support research and development in Germany.The company has urged the German government …

News

PRA International expands European presence

December 9, 2008
Medical Communications Germany, PRA

Contract research organisation PRA International has opened a new office in Munich, its third base in Germany. Several major pharmaceutical …

News

Plavix faces generic challenge in Germany

May 16, 2008
Sales and Marketing Germany, generics

Sanofi-Aventis and Bristol-Myers Squibb are feeling the heat from a Swiss drugs company which intends to market a generic version …

News

Germany loses out in Astellas restructuring

August 2, 2007
Sales and Marketing Astellas, Germany

Astellas has announced streamlining and cutbacks to its operations across Europe, with operations in Germany losing staff in its saleforce …

News
The Gateway to Local Adoption Series

Latest content

Sandoz launches allergy relief nasal spray in Germany and Switzerland

April 9, 2026

Japan approve Daiichi Sankyo’s Enhertu as a second-line treatment for gastric cancer

April 9, 2026

Trelleborg to take part in Medtec Japan 2026

April 8, 2026

Kainova Therapeutics expands phase I/II trial of antibody drug

April 7, 2026

Eisai starts enrolment for phase 2 narcolepsy study evaluating E2086

April 7, 2026